Associated Papers
First-Line Pyrotinib Combination Therapy for HER2-Mutated Advanced NSCLC: A Retrospective Cohort Analysis.
Xiang Y et al.
Current Oncology (toronto, Ont.), 2025
40136352 (PubMed )
Supplement: curroncol-32-00148-s001.zip › HER2_Raw_data.xls › Sheet1
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis.
Rossi T et al.
Cancers, 2022
36010918 (PubMed )
Supplement: cancers-14-03925-s001.zip › Supplementary_Material_Table_S1.pdf
Select a paper to view details